Why Inventory Visibility Matters–and How to Achieve it at Scale
Consumers today can track a $40 food delivery in real time from restaurant pickup to doorstep arrival. Yet many pharmaceutical supply chains still operate with fragmented visibility across products worth hundreds of thousands or millions of dollars.
That gap is becoming increasingly unsustainable with the rise of just-in-time inventory models, specialty pharmaceuticals, biologics, and personalized therapies. Overall, healthcare supply chains are under pressure to improve:
- lot-level traceability
- expiry visibility
- serialization readiness
- inventory forecasting
- DSCSA compliance
- real-time operational transparency
These are exactly the challenges Ryan Oppel and Jeff Gainer, supply chain leaders at LifeScience Logistics (LSL), are focused on solving at scale.
This article highlights how to achieve true inventory visibility, and why it is so important, including:
- the real cost of poor inventory visibility
- what lot and expiry tracking actually requires operationally
- where automation creates the most value in pharmaceutical 3PL
- why healthcare supply chains must rethink how visibility, automation, and human decision-making work together
The Real Cost of Poor Inventory Visibility
When manufacturers, health systems, or distributors lack real-time inventory visibility, the downstream impact rarely appears immediately.
Instead, problems compound quietly:
- short-dated inventory
- avoidable waste
- stock imbalances
- forecasting failures
- delayed shipments
- product quarantines
- patient disruption
In pharmaceutical supply chains operating under just-in-time inventory models, even small visibility gaps can create major downstream consequences.
“With the cost of pharmaceutical inventory being so high, many organizations are moving toward just-in-time delivery models to minimize cash flow impact, without fully understanding how JIT can compromise patient outcomes.”
– Ryan Oppel, Chief Commercial Officer, LifeScience Logistics
A one- or two-day supply disruption may seem operationally minor. For patients dependent on critical therapies, it can mean delayed treatment or missed care entirely.
“Being able to forecast inventory capabilities and capacities is critical in preventing waste. There are opportunities for impact both upstream and downstream across the supply chain.”
– Jeff Gainer, Director of Business Enablement at LifeScience Logistics
The core issue is not simply knowing what inventory exists.
It is generating accurate operational signals across manufacturers, providers, distributors, and logistics partners to balance:
- inventory efficiency
- product availability
- waste reduction
- patient continuity of care
What True Inventory Visibility Looks Like at Scale
In healthcare logistics, visibility is easy to promise and difficult to operationalize at scale.
Ryan Oppel, Chief Commercial Officer at LifeScience Logistics, explains the challenge plainly:
“When you’re dealing with a building that has over 100,000 pallet positions, with millions of cases and potentially hundreds of millions of individual parts, you need traceability down to that needle in a haystack.”
For LSL, that means a unified Enterprise Resource Planning (ERP) environment that provides consistent inventory intelligence across the network instead of disconnected site-level systems that require manual reconciliation.
The objective is complete lot-, SKU-, and unit-level traceability regardless of where inventory resides within the network.
As DSCSA enforcement and healthcare supply chain complexity continue to increase, organizations can no longer rely on fragmented operational visibility or delayed reporting cycles.
They need real-time operational awareness.
Jeff Gainer, Director of Business Enablement at LSL, points to the digital infrastructure required to support that level of traceability: “The biggest thing is implementing electronic touchpoints across the process — barcode scanning, WMS integration, serialization tracking — so we can see every unit every time it’s touched from receiving through outbound shipment.”
That level of serialized control is becoming essential not only for compliance, but for rapid exception management, audit readiness, and patient protection.
For organizations requiring deeper integration, LSL also supports direct ERP connectivity and real-time data transmission across customer systems and operational workflows.
The Operational Foundation Visibility Depends On
One of the most common misconceptions in healthcare logistics is that visibility can be solved with software alone.
It cannot.
Real-time inventory visibility depends on operational discipline, system interoperability, and data integrity across the supply chain.
Ryan summarizes the challenge this way: “You have to be digitally connected across the board with touchpoints at every component while maintaining compliant data storage and sharing the right layers of information to support decision-making.”
Two foundational areas determine whether visibility initiatives succeed or fail.
1. Master Data Governance
Visibility is only as reliable as the underlying master data supporting the system.
Even sophisticated WMS and ERP environments become unreliable when inventory attributes, serialization data, or product hierarchies are inconsistent across platforms.
Without strong governance, organizations create operational blind spots instead of operational control.
2. Integration Architecture
True healthcare supply chain visibility requires interoperability across manufacturers, distributors, providers, and logistics partners.
Disconnected systems create fragmented visibility at every handoff point.
As supply chains become more specialized and decentralized, integration architecture becomes just as important as physical infrastructure.
Why Lot and Expiry Initiatives Often Fail
Most failures in lot and expiry management are not caused by technology limitations.
They are caused by implementation failures.
Organizations frequently attempt to layer automation and visibility tools onto workflows that were never standardized in the first place. The result is added operational burden instead of improved control.
LSL approaches implementation differently.
“A big component of effectively managing an ongoing program is kicking it off the right way,” Ryan explains. “We spend significant time upfront identifying what information will be collected, how it will move through the system, and who owns each communication path.”
That process begins before inventory is ever received.
LSL conducts multi-day onboarding sessions that bring together operational, quality, IT, compliance, and customer stakeholders to align around:
- workflow mapping
- data ownership
- escalation procedures
- change management
- communication protocols
- exception handling
The objective is establishing operational consistency before scale begins.
That upfront rigor reduces downstream friction, minimizes manual intervention, and improves scalability over time.
Jeff describes the automation philosophy similarly: “The best approach is understanding the process first — identifying what’s critical, determining what can be automated effectively, and scaling responsibly where automation adds value.”
The Operational Controls Behind Healthcare Inventory Management
Effective healthcare inventory management depends on disciplined inventory controls embedded directly into warehouse workflows.
At LSL, those controls include:
FEFO and FIFO Enforcement
LSL’s WMS applies FEFO (first-expired, first-out) and FIFO inventory logic to reduce waste and prevent outdated inventory from being selected when newer product is available.
Recall and Quarantine Controls
In recall or quality events, location-level hold codes immediately prevent affected inventory from moving through the system both digitally and physically.
This allows rapid containment while maintaining traceability throughout the investigation process.
Risk-Based Cycle Counting
Cycle counting is driven by operational risk factors including:
- product value
- transaction velocity
- anomaly detection
- regulatory sensitivity
- inventory movement frequency
This creates greater oversight for high-risk inventory without relying on blanket manual counts across all products.
Where Automation Creates the Most Value
The healthcare automation conversation is often framed incorrectly.
The question is not whether organizations should automate.
The real question is where automation improves:
- patient protection
- operational accuracy
- scalability
- compliance
- traceability
- responsiveness
LSL’s philosophy combines the nuance of human insight with the efficiency of automation.
“Automation improves patient protection, strengthens compliance, enhances traceability, and supports scalability across highly complex healthcare supply chains.”
– Jeff Gainer, Director of Business Enablement at LifeScience Logistics
In practice, that includes:
- serialization tracking
- real-time temperature monitoring
- automated exception alerts
- inventory movement visibility
- ERP/WMS synchronization
- induction and put-away optimization
- picking workflow automation
But LSL deliberately avoids automating areas where human judgment creates greater value.
“We’re not removing critical thinking from our people,” Ryan explains. “We’re empowering them to make better decisions faster.”
Jeff reinforces the same philosophy: “Automation should handle repetitive operational work. Our people should focus on the decisions that require judgment, experience, and problem solving.”
Where Healthcare Organizations Should Resist Automation
Both Ryan and Jeff have seen automation initiatives fail for similar reasons.
Automating Broken Processes
Scaling inefficient workflows only compounds operational problems faster.
Weak Change Management
Without organizational alignment and training, automation adoption deteriorates quickly.
Treating Automation as a One-Time IT Project
Automation is an operational capability requiring continuous refinement – not a single deployment milestone.
Misaligned Leadership Expectations
When leadership expectations around cost, timing, or ROI are unrealistic, long-term support often disappears before value is realized.
“Automation should scale excellence. It shouldn’t amplify chaos.”
– Ryan Oppel, Chief Commercial Officer, LifeScience Logistics
If workflows are undocumented, SOPs are inconsistent, or shadow processes exist outside formal systems, automation magnifies those weaknesses at scale.
Measuring Whether Automation Is Actually Working
Automation success cannot be measured by technology deployment alone.
LSL evaluates automation initiatives across four operational categories:
1. Quality, Compliance, and Risk
Every workflow must support healthcare regulatory requirements, quality standards, and patient protection expectations.
2. Customer-Facing Performance
Metrics include:
- on-time shipping
- order accuracy
- inventory visibility
- put-away accuracy
- exception response
These numbers should improve or remain stable as automation scales.
3. Operational Performance
Metrics include:
- throughput
- labor efficiency
- waste reduction
- scalability
- operational cost optimization
4. Enterprise Scalability
- facilities
- regulated product types
- customer segments
- commercial and government programs
Ultimately, Ryan argues that the most important KPI is not operational – it is clinical: “At the end of the day, patient impact has to be the driving metric.”
Visibility Is Not Optional in Healthcare Supply Chains
Healthcare supply chains are operating in an environment where:
- inventory costs are rising
- therapies are becoming more specialized
- compliance expectations are increasing
- patient tolerance for disruption is disappearing
In that environment, fragmented visibility and reactive operations are no longer sustainable.
Organizations need:
- real-time inventory intelligence
- interoperable systems
- disciplined operational controls
- scalable automation
- traceable workflows
- experienced healthcare logistics partners
At LifeScience Logistics, those capabilities are built directly into how healthcare programs are designed, implemented, and operated.
From ERP connectivity and serialized inventory management to onboarding rigor and operational governance, LSL helps pharmaceutical, biotech, and medical device organizations build more resilient and transparent supply chains.
